Dose-finding and Phase II study of the Combination of Bevacizumab rhuMAb VEGF plus low- dose Immunotherapy and Chemotherapy in patients with metastatic Renal Cell Cancer.
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2014
At a glance
- Drugs Bevacizumab (Primary) ; Aldesleukin; Fluorouracil; Gemcitabine; Interferon alpha-2a
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 26 May 2011 New trial record